Miller TR - Search Results

1

Boc-CCK-4 derivatives containing side-chain ureas as potent and selective CCK-a receptor agonists.

Shiosaki K, Lin CW, Kopecka H, Tufano MD, Bianchi BR, Miller TR, Witte DG, Nadzan AM. Shiosaki K, et al. Among authors: miller tr. J Med Chem. 1991 Sep;34(9):2837-42. doi: 10.1021/jm00113a023. J Med Chem. 1991. PMID: 1716682

2

Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N epsilon)-amide residues.

Shiosaki K, Lin CW, Kopecka H, Craig RA, Bianchi BR, Miller TR, Witte DG, Stashko M, Nadzan AM. Shiosaki K, et al. Among authors: miller tr. J Med Chem. 1992 May 29;35(11):2007-14. doi: 10.1021/jm00089a010. J Med Chem. 1992. PMID: 1375964

3

Both CCK-A and CCK-B/gastrin receptors are present on rabbit vagus nerve.

Lin CW, Miller TR. Lin CW, et al. Among authors: miller tr. Am J Physiol. 1992 Sep;263(3 Pt 2):R591-5. doi: 10.1152/ajpregu.1992.263.3.R591. Am J Physiol. 1992. PMID: 1415646

4

Synthesis and biological activity of CCK heptapeptide analogues. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity in vitro, and appetite suppression in vivo.

Holladay MW, Bennett MJ, Tufano MD, Lin CW, Asin KE, Witte DG, Miller TR, Bianchi BR, Nikkel AL, Bednarz L, et al. Holladay MW, et al. Among authors: miller tr. J Med Chem. 1992 Aug 7;35(16):2919-28. doi: 10.1021/jm00094a001. J Med Chem. 1992. PMID: 1501220

5

Both CCK-A and CCK-B/gastrin receptors mediate pepsinogen release in guinea pig gastric glands.

Lin CW, Bianchi BR, Miller TR, Witte DG, Wolfram CA. Lin CW, et al. Among authors: miller tr. Am J Physiol. 1992 Jun;262(6 Pt 1):G1113-20. doi: 10.1152/ajpgi.1992.262.6.G1113. Am J Physiol. 1992. PMID: 1616041

6

Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.

Lin CW, Shiosaki K, Miller TR, Witte DG, Bianchi BR, Wolfram CA, Kopecka H, Craig R, Wagenaar F, Nadzan AM. Lin CW, et al. Among authors: miller tr. Mol Pharmacol. 1991 Mar;39(3):346-51. Mol Pharmacol. 1991. PMID: 1706470

7

trans-3-n-propyl-L-proline is a highly favorable, conformationally restricted replacement for methionine in the C-terminal tetrapeptide of cholecystokinin. Stereoselective synthesis of 3-allyl- and 3-n-propyl-L-proline derivatives from 4-hydroxy-L-proline.

Holladay MW, Lin CW, May CS, Garvey DS, Witte DG, Miller TR, Wolfram CA, Nadzan AM. Holladay MW, et al. Among authors: miller tr. J Med Chem. 1991 Jan;34(1):455-7. doi: 10.1021/jm00105a068. J Med Chem. 1991. PMID: 1992147 No abstract available.

8

A71378: a CCK agonist with high potency and selectivity for CCK-A receptors.

Lin CW, Holladay MW, Witte DG, Miller TR, Wolfram CA, Bianchi BR, Bennett MJ, Nadzan AM. Lin CW, et al. Among authors: miller tr. Am J Physiol. 1990 Apr;258(4 Pt 1):G648-51. doi: 10.1152/ajpgi.1990.258.4.G648. Am J Physiol. 1990. PMID: 2333977

9

Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).

Lin CW, Holladay MW, Barrett RW, Wolfram CA, Miller TR, Witte D, Kerwin JF Jr, Wagenaar F, Nadzan AM. Lin CW, et al. Among authors: miller tr. Mol Pharmacol. 1989 Dec;36(6):881-6. Mol Pharmacol. 1989. PMID: 2601685

10

Novel CCK analogues and bombesin: a detailed analysis between phosphoinositide breakdown and high-dose inhibition of pancreatic enzyme secretion in three rodent species.

Bianchi BR, Miller TR, Witte DG, Lin CW. Bianchi BR, et al. Among authors: miller tr. J Pharmacol Exp Ther. 1994 Feb;268(2):996-1002. J Pharmacol Exp Ther. 1994. PMID: 7509394

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

737 results

Search Page